Abstract
The risk of non-melanoma skin cancer (NMSC) and in particular squamous cell carcinoma is significantly increased in organ transplant recipients due to long-term treatment with immunosuppressives. Dermatologic management in the form of a multidisciplinary approach, including patient education, skin surveillance and early treatment of premalignant and malignant lesions is recommended. Field-directed rather than lesional therapy is preferred for actinic keratosis in field-cancerized skin; and high-efficacy therapies are recommended in NMSC due to an increased risk of recurrences and metastases.
| Bidragets oversatte titel | Organ transplant recipients need intensive control and treatment of skin cancer |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 175 |
| Udgave nummer | 20 |
| Sider (fra-til) | 1408-11 |
| Antal sider | 4 |
| ISSN | 0041-5782 |
| Status | Udgivet - 13 maj 2013 |
Emneord
- Carcinoma, Squamous Cell
- Humans
- Immunocompromised Host
- Immunosuppressive Agents
- Keratosis, Actinic
- Organ Transplantation
- Risk Factors
- Skin Neoplasms
- Ultraviolet Rays